Publication | Open Access
Topical Administration of Lacritin Is a Novel Therapy for Aqueous-Deficient Dry Eye Disease
65
Citations
28
References
2014
Year
Lacritin is significantly reduced in the tears of SS patients. Topically administered lacritin has therapeutic potential for the treatment of aqueous-deficient dry eye disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1